REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer

Ryuta Tanimoto, Fernando Abarzua, Masakiyo Sakaguchi, Mikiro Takaishi, Yasutomo Nasu, Hiromi Kumon, Nam Ho Huh

Research output: Contribution to journalArticle

57 Citations (Scopus)

Abstract

Human testicular cancer is very sensitive to chemotherapy and radiation therapy and is regarded as a curable cancer. The cancer prevails in the young reproductive generation and testicular dysfunction is often observed as a side effect, remaining a serious challenge. In the present study, we examined the potential utility of REIC/Dkk-3-based gene therapy against human testicular cancer. Expression of REIC/Dkk-3 was reduced in all of the human seminoma and non-seminomatous germ cell tumor tissues. Overexpression of REIC/Dkk-3 using an adenovirus vector (Ad-REIC) induced apoptosis in a testicular germ cell cancer cell line NCCIT but not in normal human fibroblasts. c-Jun terminal kinase (JNK) was activated by Ad-REIC and the induction of apoptosis was abrogated by a JNK inhibitor. A single intratumoral injection of Ad-REIC markedly inhibited the tumorigenic growth of NCCIT cells in nude mice. These results indicate that Ad-REIC may lead to developing less insulting and non-genotoxic therapeutic measures against human testicular cancer.

Original languageEnglish
Pages (from-to)363-368
Number of pages6
JournalInternational Journal of Molecular Medicine
Volume19
Issue number3
Publication statusPublished - Mar 2007

Fingerprint

Testicular Neoplasms
Genes
MAP Kinase Kinase 4
Apoptosis
Therapeutics
Seminoma
Germ Cell and Embryonal Neoplasms
Adenoviridae
Nude Mice
Genetic Therapy
Neoplasms
Radiotherapy
Fibroblasts
Drug Therapy
Cell Line
Injections
Growth

Keywords

  • Dkk-3
  • NCCIT
  • REIC
  • Testicular tumor
  • Therapy

ASJC Scopus subject areas

  • Genetics

Cite this

REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer. / Tanimoto, Ryuta; Abarzua, Fernando; Sakaguchi, Masakiyo; Takaishi, Mikiro; Nasu, Yasutomo; Kumon, Hiromi; Huh, Nam Ho.

In: International Journal of Molecular Medicine, Vol. 19, No. 3, 03.2007, p. 363-368.

Research output: Contribution to journalArticle

@article{81726b814fd5434483fd882a98c52cd0,
title = "REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer",
abstract = "Human testicular cancer is very sensitive to chemotherapy and radiation therapy and is regarded as a curable cancer. The cancer prevails in the young reproductive generation and testicular dysfunction is often observed as a side effect, remaining a serious challenge. In the present study, we examined the potential utility of REIC/Dkk-3-based gene therapy against human testicular cancer. Expression of REIC/Dkk-3 was reduced in all of the human seminoma and non-seminomatous germ cell tumor tissues. Overexpression of REIC/Dkk-3 using an adenovirus vector (Ad-REIC) induced apoptosis in a testicular germ cell cancer cell line NCCIT but not in normal human fibroblasts. c-Jun terminal kinase (JNK) was activated by Ad-REIC and the induction of apoptosis was abrogated by a JNK inhibitor. A single intratumoral injection of Ad-REIC markedly inhibited the tumorigenic growth of NCCIT cells in nude mice. These results indicate that Ad-REIC may lead to developing less insulting and non-genotoxic therapeutic measures against human testicular cancer.",
keywords = "Dkk-3, NCCIT, REIC, Testicular tumor, Therapy",
author = "Ryuta Tanimoto and Fernando Abarzua and Masakiyo Sakaguchi and Mikiro Takaishi and Yasutomo Nasu and Hiromi Kumon and Huh, {Nam Ho}",
year = "2007",
month = "3",
language = "English",
volume = "19",
pages = "363--368",
journal = "International Journal of Molecular Medicine",
issn = "1107-3756",
publisher = "Spandidos Publications",
number = "3",

}

TY - JOUR

T1 - REIC/Dkk-3 as a potential gene therapeutic agent against human testicular cancer

AU - Tanimoto, Ryuta

AU - Abarzua, Fernando

AU - Sakaguchi, Masakiyo

AU - Takaishi, Mikiro

AU - Nasu, Yasutomo

AU - Kumon, Hiromi

AU - Huh, Nam Ho

PY - 2007/3

Y1 - 2007/3

N2 - Human testicular cancer is very sensitive to chemotherapy and radiation therapy and is regarded as a curable cancer. The cancer prevails in the young reproductive generation and testicular dysfunction is often observed as a side effect, remaining a serious challenge. In the present study, we examined the potential utility of REIC/Dkk-3-based gene therapy against human testicular cancer. Expression of REIC/Dkk-3 was reduced in all of the human seminoma and non-seminomatous germ cell tumor tissues. Overexpression of REIC/Dkk-3 using an adenovirus vector (Ad-REIC) induced apoptosis in a testicular germ cell cancer cell line NCCIT but not in normal human fibroblasts. c-Jun terminal kinase (JNK) was activated by Ad-REIC and the induction of apoptosis was abrogated by a JNK inhibitor. A single intratumoral injection of Ad-REIC markedly inhibited the tumorigenic growth of NCCIT cells in nude mice. These results indicate that Ad-REIC may lead to developing less insulting and non-genotoxic therapeutic measures against human testicular cancer.

AB - Human testicular cancer is very sensitive to chemotherapy and radiation therapy and is regarded as a curable cancer. The cancer prevails in the young reproductive generation and testicular dysfunction is often observed as a side effect, remaining a serious challenge. In the present study, we examined the potential utility of REIC/Dkk-3-based gene therapy against human testicular cancer. Expression of REIC/Dkk-3 was reduced in all of the human seminoma and non-seminomatous germ cell tumor tissues. Overexpression of REIC/Dkk-3 using an adenovirus vector (Ad-REIC) induced apoptosis in a testicular germ cell cancer cell line NCCIT but not in normal human fibroblasts. c-Jun terminal kinase (JNK) was activated by Ad-REIC and the induction of apoptosis was abrogated by a JNK inhibitor. A single intratumoral injection of Ad-REIC markedly inhibited the tumorigenic growth of NCCIT cells in nude mice. These results indicate that Ad-REIC may lead to developing less insulting and non-genotoxic therapeutic measures against human testicular cancer.

KW - Dkk-3

KW - NCCIT

KW - REIC

KW - Testicular tumor

KW - Therapy

UR - http://www.scopus.com/inward/record.url?scp=33947520510&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947520510&partnerID=8YFLogxK

M3 - Article

VL - 19

SP - 363

EP - 368

JO - International Journal of Molecular Medicine

JF - International Journal of Molecular Medicine

SN - 1107-3756

IS - 3

ER -